自閉症スペクトラム治療の世界市場規模、シェア、産業動向分析レポート：タイプ別、用途別、流通チャネル別、地域別展望と予測、2023年～2030年

自閉症スペクトラム治療市場規模は2030年までに30億米ドルに達すると予測され、予測期間中のCAGRは6.2%の市場成長率で上昇します。

さらに、COVID-19パンデミックの初期段階では、多くのヘルスケア事業が閉鎖を余儀なくされ、生産が鈍化しました。パンデミックは、治療セッション、言語療法、作業療法を含む多くの対面サービスを中断させました。しかし、サービスの中断に対処するため、遠隔医療や遠隔療法の選択肢がより広く採用されるようになっています。多くのセラピストやヘルスケアプロバイダーが、遠隔での相談やセラピーセッションを提供し始めました。患者の介護者/家族による遠隔医療システムの急速な受け入れは、ASD患者の不安レベルの上昇と、これらの患者が脆弱なカテゴリーに含まれるため、COVID-19に感染する可能性によって促されました。さらに、COVID-19の間に市場が拡大したのは、自閉症の治療薬を購入するためのオンラインソースの利用が増加したためです。

しかし、自閉症の効果的な治療薬や臨床研究に対する需要が高まっているにもかかわらず、自閉症スペクトラムの主な症状を完全に緩和できる薬はまだないです。何度も試みられているにもかかわらず、この症状の主な症状に対する治療薬の有効性を示す具体的な証拠は、標的治療の現代ではまだないです。その結果、治療法の開発はより困難なものとなり、自閉症スペクトラムの患者に対する治療法の需要は低下しています。したがって、患者を治療するための承認薬が存在しないことが、市場の拡大を妨げる可能性があります。

タイプ別展望

タイプ別に見ると、抗精神病薬、選択的セロトニン再取り込み阻害薬、刺激薬、睡眠薬、その他に分類されます。覚せい剤セグメントは、2022年の市場で最も高い収益シェアを獲得しました。同分野の拡大は、患者の薬へのアクセスや入手のしやすさが向上していることに起因しています。米国FDAは、デキセドリン、フォカリン、バイバンセ、アデロール、リタリンなど、自閉症患者の治療薬として複数の覚せい剤を認可しています。これらの薬剤が患者に適切に供給されれば、症状は80％軽減します。したがって、刺激薬の高い効能は、新たなターゲット顧客を引き寄せ、収入源を多様化させる可能性があります。

用途別展望

用途別に見ると、市場は自閉性障害、アスペルガー症候群、広汎性発達障害、その他に分類されます。アスペルガー症候群セグメントは、2022年の市場で大きな収益シェアを記録しました。アスペルガー症候群の患者は、一般的に社会的相互作用が困難です。表情や身振り手振りのような非言語的な合図を理解することに苦労し、典型的な社会的交流に参加することが困難になることがあります。アスペルガー症候群の人に共通する特徴は、会話中のアイコンタクトが限られていることです。社会的交流の間、特定のレベルのアイコンタクトを維持できないことがあります。アスペルガー症候群の人は、ふりをしたり、自分の経験とは異なるシナリオを想像したりすることに困難を感じることがあります。

流通チャネルの展望

流通チャネル別に見ると、市場は病院薬局、小売薬局、オンライン薬局に分けられます。2022年の市場では、小売薬局セグメントが最大の売上シェアを占めています。抗けいれん薬、三環系抗うつ薬、興奮薬、SSRI、不安薬などの医薬品は、小売薬局で広く入手可能です。このように様々な医薬品が広く入手可能であることが、市場セグメントの成長の要因となっています。2021年6月の記事によると、ASD患者の30%から50%は、上記の薬剤のうち少なくとも一つを服用していると考えられています。その結果、ASD人口の増加により、このセグメントの成長が大きく牽引されています。

地域別展望

地域別に見ると、市場は北米、欧州、アジア太平洋、LAMEAで分析されます。北米セグメントは2022年の市場で最も高い収益シェアを獲得しました。ASDの有病率は北米および世界的に増加しています。認知度の向上、診断基準の改善、ヘルスケアサービスへのアクセスの向上が、診断率の向上に寄与しています。ASDと診断される人が増えるにつれて、治療や支援サービスに対する需要も増加しています。北米の多くの地域では、自閉症関連の治療や介入に対する保険適用の確保が進んでいます。ASD治療への保険適用を義務付ける法律や規制により、ケアへのアクセスが拡大しています。

目次

第1章 市場範囲と調査手法

• 市場の定義
• 目的
• 市場範囲
• セグメンテーション
• 調査手法

第2章 市場の概要

• 主なハイライト

第3章 市場概要

• イントロダクション
  • 概要
    • 市場構成とシナリオ
• 市場に影響を与える主な要因
  • 市場促進要因
  • 市場抑制要因
• ポーターファイブフォース分析

第4章 世界の自閉症スペクトラム障害治療市場：タイプ別

• 世界の覚せい剤市場：地域別
• 世界の抗精神病薬市場：地域別
• 世界の選択的セロトニン再取り込み阻害剤市場：地域別
• 世界の睡眠薬市場：地域別
• 世界のその他の市場：地域別

第5章 世界の市場：、アプリケーション別

• 世界の自閉症障害市場：地域別
• 世界のアスペルガー症候群市場：地域別
• 世界の広汎性発達障害市場：地域別
• 世界のその他の市場：地域別

第6章 世界の市場：、流通チャネル別

• 世界の小売薬局市場：地域別
• 世界の病院薬局市場：地域別
• 世界のオンライン薬局市場：地域別

第7章 世界の市場：、地域別

• 北米の市場
  • 北米の市場：タイプ別
    • 北米の国別覚せい剤市場
    • 北米の国別抗精神病薬市場
    • 北米の国別選択的セロトニン再取り込み阻害剤市場
    • 北米の国別睡眠薬市場
    • 北米その他の国別市場
  • 北米の市場：用途別
    • 北米の国別自閉症障害市場
    • 北米の国別アスペルガー症候群市場
    • 北米の国別広汎性発達障害市場
    • 北米その他の国別市場
  • 北米の市場：流通チャネル別
    • 北米の国別小売薬局市場
    • 北米の国別病院薬局市場
    • 北米の国別オンライン薬局市場
  • 北米の市場：国別
    • 米国の自閉症スペクトラム障害治療市場
    • カナダの自閉症スペクトラム障害治療市場
    • メキシコの自閉症スペクトラム障害治療市場
    • 残りの北米の市場
• 欧州の市場
  • 欧州の市場：タイプ別
    • 国別の欧州覚せい剤市場
    • 欧州の国別抗精神病薬市場
    • 欧州の国別選択的セロトニン再取り込み阻害剤市場
    • 欧州の国別睡眠薬市場
    • 欧州その他の国別市場
  • 欧州の市場：用途別
    • 欧州の国別自閉症障害市場
    • 欧州の国別アスペルガー症候群市場
    • 欧州の国別広汎性発達障害市場
    • 欧州その他の国別市場
  • 欧州の市場：流通チャネル別
    • 欧州の国別小売薬局市場
    • 欧州の国別病院薬局市場
    • 欧州の国別オンライン薬局市場
  • 欧州の市場：国別
    • ドイツの自閉症スペクトラム障害治療市場
    • 英国の自閉症スペクトラム障害治療市場
    • フランスの自閉症スペクトラム障害治療市場
    • ロシアの自閉症スペクトラム障害治療市場
    • スペインの自閉症スペクトラム障害治療市場
    • イタリアの自閉症スペクトラム障害治療市場
    • 残りの欧州の市場
• アジア太平洋の市場
  • アジア太平洋の市場：タイプ別
    • アジア太平洋地域の国別覚せい剤市場
    • アジア太平洋地域の国別抗精神病薬市場
    • アジア太平洋地域の国別選択的セロトニン再取り込み阻害剤市場
    • アジア太平洋地域の国別睡眠薬市場
    • アジア太平洋地域その他の国別市場
  • アジア太平洋の市場：用途別
    • アジア太平洋地域の国別自閉症障害市場
    • アジア太平洋地域の国別アスペルガー症候群市場
    • アジア太平洋地域の国別広汎性発達障害市場
    • アジア太平洋地域その他の国別市場
  • アジア太平洋の市場：流通チャネル別
    • アジア太平洋地域の国別小売薬局市場
    • アジア太平洋地域の病院薬局市場：（国別）
    • アジア太平洋地域の国別オンライン薬局市場
  • アジア太平洋の市場：国別
    • 中国自閉症スペクトラム障害治療市場
    • 日本の自閉症スペクトラム障害治療市場
    • インドの自閉症スペクトラム障害治療市場
    • 韓国の自閉症スペクトラム障害治療市場
    • シンガポールの自閉症スペクトラム障害治療市場
    • マレーシアの自閉症スペクトラム障害治療市場
    • 残りのアジア太平洋の市場
• ラテンアメリカ・中東・アフリカの市場
  • ラテンアメリカ・中東・アフリカの市場：タイプ別
    • 国別LAMEA覚せい剤市場
    • 国別のLAMEA抗精神病薬市場
    • 国別のLAMEA選択的セロトニン再取り込み阻害剤市場
    • 国別のLAMEA睡眠薬市場
    • 国別LAMEAその他市場
  • ラテンアメリカ・中東・アフリカの市場：用途別
    • 国別LAMEA自閉症障害市場
    • 国別LAMEAアスペルガー症候群市場
    • 国別のLAMEA広汎性発達障害市場
    • 国別LAMEAその他市場
  • ラテンアメリカ・中東・アフリカの市場：流通チャネル別
    • 国別LAMEA小売薬局市場
    • 国別のLAMEA病院薬局市場
    • 国別のLAMEAオンライン薬局市場
  • ラテンアメリカ・中東・アフリカの市場：国別
    • ブラジルの自閉症スペクトラム障害治療市場
    • アルゼンチンの自閉症スペクトラム障害治療市場
    • UAEの自閉症スペクトラム障害治療市場
    • サウジアラビアの自閉症スペクトラム障害治療市場
    • 南アフリカの自閉症スペクトラム障害治療市場
    • ナイジェリアの自閉症スペクトラム障害治療市場
    • 残りのラテンアメリカ・中東・アフリカの市場

第8章 企業プロファイル

• F Hoffmann-La Roche Ltd.
• Bristol Myers Squibb Company
• Merck & Co, Inc.
• Novartis AG
• Eli Lilly And Company
• Pfizer, Inc
• Johnson & Johnson
• Otsuka Pharmaceutical Co, Ltd.
• Yamo Pharmaceuticals
• Curemark, LLC

第9章 自閉症スペクトラム障害治療市場の勝利の必須事項

LIST OF TABLES

• TABLE 1 Global Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 2 Global Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 3 Global Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
• TABLE 4 Global Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
• TABLE 5 Global Stimulants Market, by Region, 2019 - 2022, USD Million
• TABLE 6 Global Stimulants Market, by Region, 2023 - 2030, USD Million
• TABLE 7 Global Antipsychotic Drugs Market, by Region, 2019 - 2022, USD Million
• TABLE 8 Global Antipsychotic Drugs Market, by Region, 2023 - 2030, USD Million
• TABLE 9 Global Selective Serotonin Reuptake Inhibitors Market, by Region, 2019 - 2022, USD Million
• TABLE 10 Global Selective Serotonin Reuptake Inhibitors Market, by Region, 2023 - 2030, USD Million
• TABLE 11 Global Sleep Medications Market, by Region, 2019 - 2022, USD Million
• TABLE 12 Global Sleep Medications Market, by Region, 2023 - 2030, USD Million
• TABLE 13 Global Others Market, by Region, 2019 - 2022, USD Million
• TABLE 14 Global Others Market, by Region, 2023 - 2030, USD Million
• TABLE 15 Global Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
• TABLE 16 Global Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
• TABLE 17 Global Autistic Disorder Market, by Region, 2019 - 2022, USD Million
• TABLE 18 Global Autistic Disorder Market, by Region, 2023 - 2030, USD Million
• TABLE 19 Global Asperger Syndrome Market, by Region, 2019 - 2022, USD Million
• TABLE 20 Global Asperger Syndrome Market, by Region, 2023 - 2030, USD Million
• TABLE 21 Global Pervasive Developmental Disorder Market, by Region, 2019 - 2022, USD Million
• TABLE 22 Global Pervasive Developmental Disorder Market, by Region, 2023 - 2030, USD Million
• TABLE 23 Global Others Market, by Region, 2019 - 2022, USD Million
• TABLE 24 Global Others Market, by Region, 2023 - 2030, USD Million
• TABLE 25 Global Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
• TABLE 26 Global Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
• TABLE 27 Global Retail Pharmacy Market, by Region, 2019 - 2022, USD Million
• TABLE 28 Global Retail Pharmacy Market, by Region, 2023 - 2030, USD Million
• TABLE 29 Global Hospital Pharmacy Market, by Region, 2019 - 2022, USD Million
• TABLE 30 Global Hospital Pharmacy Market, by Region, 2023 - 2030, USD Million
• TABLE 31 Global Online Pharmacy Market, by Region, 2019 - 2022, USD Million
• TABLE 32 Global Online Pharmacy Market, by Region, 2023 - 2030, USD Million
• TABLE 33 Global Autism Spectrum Disorder Treatment Market, by Region, 2019 - 2022, USD Million
• TABLE 34 Global Autism Spectrum Disorder Treatment Market, by Region, 2023 - 2030, USD Million
• TABLE 35 North America Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 36 North America Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 37 North America Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
• TABLE 38 North America Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
• TABLE 39 North America Stimulants Market, by Country, 2019 - 2022, USD Million
• TABLE 40 North America Stimulants Market, by Country, 2023 - 2030, USD Million
• TABLE 41 North America Antipsychotic Drugs Market, by Country, 2019 - 2022, USD Million
• TABLE 42 North America Antipsychotic Drugs Market, by Country, 2023 - 2030, USD Million
• TABLE 43 North America Selective Serotonin Reuptake Inhibitors Market, by Country, 2019 - 2022, USD Million
• TABLE 44 North America Selective Serotonin Reuptake Inhibitors Market, by Country, 2023 - 2030, USD Million
• TABLE 45 North America Sleep Medications Market, by Country, 2019 - 2022, USD Million
• TABLE 46 North America Sleep Medications Market, by Country, 2023 - 2030, USD Million
• TABLE 47 North America Others Market, by Country, 2019 - 2022, USD Million
• TABLE 48 North America Others Market, by Country, 2023 - 2030, USD Million
• TABLE 49 North America Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
• TABLE 50 North America Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
• TABLE 51 North America Autistic Disorder Market, by Country, 2019 - 2022, USD Million
• TABLE 52 North America Autistic Disorder Market, by Country, 2023 - 2030, USD Million
• TABLE 53 North America Asperger Syndrome Market, by Country, 2019 - 2022, USD Million
• TABLE 54 North America Asperger Syndrome Market, by Country, 2023 - 2030, USD Million
• TABLE 55 North America Pervasive Developmental Disorder Market, by Country, 2019 - 2022, USD Million
• TABLE 56 North America Pervasive Developmental Disorder Market, by Country, 2023 - 2030, USD Million
• TABLE 57 North America Others Market, by Country, 2019 - 2022, USD Million
• TABLE 58 North America Others Market, by Country, 2023 - 2030, USD Million
• TABLE 59 North America Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
• TABLE 60 North America Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
• TABLE 61 North America Retail Pharmacy Market, by Country, 2019 - 2022, USD Million
• TABLE 62 North America Retail Pharmacy Market, by Country, 2023 - 2030, USD Million
• TABLE 63 North America Hospital Pharmacy Market, by Country, 2019 - 2022, USD Million
• TABLE 64 North America Hospital Pharmacy Market, by Country, 2023 - 2030, USD Million
• TABLE 65 North America Online Pharmacy Market, by Country, 2019 - 2022, USD Million
• TABLE 66 North America Online Pharmacy Market, by Country, 2023 - 2030, USD Million
• TABLE 67 North America Autism Spectrum Disorder Treatment Market, by Country, 2019 - 2022, USD Million
• TABLE 68 North America Autism Spectrum Disorder Treatment Market, by Country, 2023 - 2030, USD Million
• TABLE 69 US Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 70 US Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 71 US Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
• TABLE 72 US Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
• TABLE 73 US Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
• TABLE 74 US Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
• TABLE 75 US Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
• TABLE 76 US Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
• TABLE 77 Canada Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 78 Canada Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 79 Canada Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
• TABLE 80 Canada Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
• TABLE 81 Canada Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
• TABLE 82 Canada Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
• TABLE 83 Canada Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
• TABLE 84 Canada Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
• TABLE 85 Mexico Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 86 Mexico Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 87 Mexico Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
• TABLE 88 Mexico Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
• TABLE 89 Mexico Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
• TABLE 90 Mexico Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
• TABLE 91 Mexico Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
• TABLE 92 Mexico Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
• TABLE 93 Rest of North America Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 94 Rest of North America Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 95 Rest of North America Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
• TABLE 96 Rest of North America Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
• TABLE 97 Rest of North America Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
• TABLE 98 Rest of North America Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
• TABLE 99 Rest of North America Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
• TABLE 100 Rest of North America Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
• TABLE 101 Europe Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 102 Europe Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 103 Europe Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
• TABLE 104 Europe Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
• TABLE 105 Europe Stimulants Market, by Country, 2019 - 2022, USD Million
• TABLE 106 Europe Stimulants Market, by Country, 2023 - 2030, USD Million
• TABLE 107 Europe Antipsychotic Drugs Market, by Country, 2019 - 2022, USD Million
• TABLE 108 Europe Antipsychotic Drugs Market, by Country, 2023 - 2030, USD Million
• TABLE 109 Europe Selective Serotonin Reuptake Inhibitors Market, by Country, 2019 - 2022, USD Million
• TABLE 110 Europe Selective Serotonin Reuptake Inhibitors Market, by Country, 2023 - 2030, USD Million
• TABLE 111 Europe Sleep Medications Market, by Country, 2019 - 2022, USD Million
• TABLE 112 Europe Sleep Medications Market, by Country, 2023 - 2030, USD Million
• TABLE 113 Europe Others Market, by Country, 2019 - 2022, USD Million
• TABLE 114 Europe Others Market, by Country, 2023 - 2030, USD Million
• TABLE 115 Europe Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
• TABLE 116 Europe Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
• TABLE 117 Europe Autistic Disorder Market, by Country, 2019 - 2022, USD Million
• TABLE 118 Europe Autistic Disorder Market, by Country, 2023 - 2030, USD Million
• TABLE 119 Europe Asperger Syndrome Market, by Country, 2019 - 2022, USD Million
• TABLE 120 Europe Asperger Syndrome Market, by Country, 2023 - 2030, USD Million
• TABLE 121 Europe Pervasive Developmental Disorder Market, by Country, 2019 - 2022, USD Million
• TABLE 122 Europe Pervasive Developmental Disorder Market, by Country, 2023 - 2030, USD Million
• TABLE 123 Europe Others Market, by Country, 2019 - 2022, USD Million
• TABLE 124 Europe Others Market, by Country, 2023 - 2030, USD Million
• TABLE 125 Europe Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
• TABLE 126 Europe Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
• TABLE 127 Europe Retail Pharmacy Market, by Country, 2019 - 2022, USD Million
• TABLE 128 Europe Retail Pharmacy Market, by Country, 2023 - 2030, USD Million
• TABLE 129 Europe Hospital Pharmacy Market, by Country, 2019 - 2022, USD Million
• TABLE 130 Europe Hospital Pharmacy Market, by Country, 2023 - 2030, USD Million
• TABLE 131 Europe Online Pharmacy Market, by Country, 2019 - 2022, USD Million
• TABLE 132 Europe Online Pharmacy Market, by Country, 2023 - 2030, USD Million
• TABLE 133 Europe Autism Spectrum Disorder Treatment Market, by Country, 2019 - 2022, USD Million
• TABLE 134 Europe Autism Spectrum Disorder Treatment Market, by Country, 2023 - 2030, USD Million
• TABLE 135 Germany Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 136 Germany Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 137 Germany Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
• TABLE 138 Germany Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
• TABLE 139 Germany Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
• TABLE 140 Germany Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
• TABLE 141 Germany Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
• TABLE 142 Germany Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
• TABLE 143 UK Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 144 UK Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 145 UK Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
• TABLE 146 UK Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
• TABLE 147 UK Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
• TABLE 148 UK Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
• TABLE 149 UK Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
• TABLE 150 UK Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
• TABLE 151 France Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 152 France Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 153 France Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
• TABLE 154 France Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
• TABLE 155 France Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
• TABLE 156 France Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
• TABLE 157 France Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
• TABLE 158 France Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
• TABLE 159 Russia Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 160 Russia Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 161 Russia Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
• TABLE 162 Russia Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
• TABLE 163 Russia Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
• TABLE 164 Russia Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
• TABLE 165 Russia Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
• TABLE 166 Russia Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
• TABLE 167 Spain Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 168 Spain Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 169 Spain Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
• TABLE 170 Spain Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
• TABLE 171 Spain Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
• TABLE 172 Spain Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
• TABLE 173 Spain Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
• TABLE 174 Spain Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
• TABLE 175 Italy Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 176 Italy Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 177 Italy Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
• TABLE 178 Italy Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
• TABLE 179 Italy Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
• TABLE 180 Italy Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
• TABLE 181 Italy Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
• TABLE 182 Italy Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
• TABLE 183 Rest of Europe Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 184 Rest of Europe Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 185 Rest of Europe Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
• TABLE 186 Rest of Europe Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
• TABLE 187 Rest of Europe Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
• TABLE 188 Rest of Europe Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
• TABLE 189 Rest of Europe Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
• TABLE 190 Rest of Europe Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
• TABLE 191 Asia Pacific Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 192 Asia Pacific Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 193 Asia Pacific Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
• TABLE 194 Asia Pacific Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
• TABLE 195 Asia Pacific Stimulants Market, by Country, 2019 - 2022, USD Million
• TABLE 196 Asia Pacific Stimulants Market, by Country, 2023 - 2030, USD Million
• TABLE 197 Asia Pacific Antipsychotic Drugs Market, by Country, 2019 - 2022, USD Million
• TABLE 198 Asia Pacific Antipsychotic Drugs Market, by Country, 2023 - 2030, USD Million
• TABLE 199 Asia Pacific Selective Serotonin Reuptake Inhibitors Market, by Country, 2019 - 2022, USD Million
• TABLE 200 Asia Pacific Selective Serotonin Reuptake Inhibitors Market, by Country, 2023 - 2030, USD Million
• TABLE 201 Asia Pacific Sleep Medications Market, by Country, 2019 - 2022, USD Million
• TABLE 202 Asia Pacific Sleep Medications Market, by Country, 2023 - 2030, USD Million
• TABLE 203 Asia Pacific Others Market, by Country, 2019 - 2022, USD Million
• TABLE 204 Asia Pacific Others Market, by Country, 2023 - 2030, USD Million
• TABLE 205 Asia Pacific Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
• TABLE 206 Asia Pacific Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
• TABLE 207 Asia Pacific Autistic Disorder Market, by Country, 2019 - 2022, USD Million
• TABLE 208 Asia Pacific Autistic Disorder Market, by Country, 2023 - 2030, USD Million
• TABLE 209 Asia Pacific Asperger Syndrome Market, by Country, 2019 - 2022, USD Million
• TABLE 210 Asia Pacific Asperger Syndrome Market, by Country, 2023 - 2030, USD Million
• TABLE 211 Asia Pacific Pervasive Developmental Disorder Market, by Country, 2019 - 2022, USD Million
• TABLE 212 Asia Pacific Pervasive Developmental Disorder Market, by Country, 2023 - 2030, USD Million
• TABLE 213 Asia Pacific Others Market, by Country, 2019 - 2022, USD Million
• TABLE 214 Asia Pacific Others Market, by Country, 2023 - 2030, USD Million
• TABLE 215 Asia Pacific Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
• TABLE 216 Asia Pacific Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
• TABLE 217 Asia Pacific Retail Pharmacy Market, by Country, 2019 - 2022, USD Million
• TABLE 218 Asia Pacific Retail Pharmacy Market, by Country, 2023 - 2030, USD Million
• TABLE 219 Asia Pacific Hospital Pharmacy Market, by Country, 2019 - 2022, USD Million
• TABLE 220 Asia Pacific Hospital Pharmacy Market, by Country, 2023 - 2030, USD Million
• TABLE 221 Asia Pacific Online Pharmacy Market, by Country, 2019 - 2022, USD Million
• TABLE 222 Asia Pacific Online Pharmacy Market, by Country, 2023 - 2030, USD Million
• TABLE 223 Asia Pacific Autism Spectrum Disorder Treatment Market, by Country, 2019 - 2022, USD Million
• TABLE 224 Asia Pacific Autism Spectrum Disorder Treatment Market, by Country, 2023 - 2030, USD Million
• TABLE 225 China Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 226 China Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 227 China Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
• TABLE 228 China Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
• TABLE 229 China Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
• TABLE 230 China Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
• TABLE 231 China Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
• TABLE 232 China Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
• TABLE 233 Japan Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 234 Japan Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 235 Japan Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
• TABLE 236 Japan Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
• TABLE 237 Japan Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
• TABLE 238 Japan Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
• TABLE 239 Japan Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
• TABLE 240 Japan Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
• TABLE 241 India Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 242 India Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 243 India Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
• TABLE 244 India Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
• TABLE 245 India Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
• TABLE 246 India Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
• TABLE 247 India Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
• TABLE 248 India Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
• TABLE 249 South Korea Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 250 South Korea Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 251 South Korea Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
• TABLE 252 South Korea Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
• TABLE 253 South Korea Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
• TABLE 254 South Korea Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
• TABLE 255 South Korea Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
• TABLE 256 South Korea Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
• TABLE 257 Singapore Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 258 Singapore Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 259 Singapore Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
• TABLE 260 Singapore Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
• TABLE 261 Singapore Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
• TABLE 262 Singapore Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
• TABLE 263 Singapore Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
• TABLE 264 Singapore Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
• TABLE 265 Malaysia Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 266 Malaysia Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 267 Malaysia Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
• TABLE 268 Malaysia Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
• TABLE 269 Malaysia Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
• TABLE 270 Malaysia Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
• TABLE 271 Malaysia Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
• TABLE 272 Malaysia Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
• TABLE 273 Rest of Asia Pacific Autism Spectrum Disorder Treatment Market, 2019 - 2022, USD Million
• TABLE 274 Rest of Asia Pacific Autism Spectrum Disorder Treatment Market, 2023 - 2030, USD Million
• TABLE 275 Rest of Asia Pacific Autism Spectrum Disorder Treatment Market, by Type, 2019 - 2022, USD Million
• TABLE 276 Rest of Asia Pacific Autism Spectrum Disorder Treatment Market, by Type, 2023 - 2030, USD Million
• TABLE 277 Rest of Asia Pacific Autism Spectrum Disorder Treatment Market, by Application, 2019 - 2022, USD Million
• TABLE 278 Rest of Asia Pacific Autism Spectrum Disorder Treatment Market, by Application, 2023 - 2030, USD Million
• TABLE 279 Rest of Asia Pacific Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
• TABLE 280 Rest of Asia Pacific Autism Spectrum Disorder Treatment Market, by Distribution Channel, 2023 - 2030, USD Million

The Global Autism Spectrum Disorder Treatment Market size is expected to reach $3.0 billion by 2030, rising at a market growth of 6.2% CAGR during the forecast period.

The patient, the caregivers, the family, and the community are all impacted by autism spectrum disorder, as it is a chronic condition. Hence, the Autistic Disorder segment captured $958.6 million revenue of the market in 2022. Every adult or child with autism faces a unique mix of difficulties, and many persons diagnosed also have other medical disorders, such as gastrointestinal (GI) distress. On the basis of this concept, numerous therapies were created. At that point, enzyme replacement therapy was established, and it has since become one of the most significant trends in the treatment of autism spectrum disorders. Some of the factors impacting the market are the rising number of initiatives by the government to raise awareness, growing prevalence of autism spectrum disorder, and slow approval rate and low availability of drugs.

The expansion of the market is being fueled by a growing array of government initiatives, such as the establishment of various foundations and the approval of different financing for autism awareness in multiple nations. Some international initiatives and organizations focus on autism-related issues, including advocacy, research, awareness, and support. International Society for Autism Research (INSAR) hosts an annual conference that brings together researchers, clinicians, and advocates worldwide. Thus, an expanding number of programs for individuals with the illness might eventually result in early symptom diagnosis and accelerate market expansion. Moreover, the market is expanding favorably as the prevalence of ASD rises, which has increased the demand for clinical research for efficient treatment. This can improve outcomes as well as help in treating certain illnesses more accurately. According to the National Library of Medicine, there were approximately 28.3 million autistic people in the world in 2019. Due to the rising need for potent medications, it is also projected that the rising prevalence rate in emerging nations would be one of the main drivers of market expansion. Therefore, the increasing prevalence of ASD will support the market's growth prospects throughout the forecast period.

Furthermore, during the early phases of the COVID-19 pandemic, many healthcare businesses were forced to close their doors, which slowed down production. The pandemic disrupted many in-person services, including therapy sessions, speech therapy, and occupational therapy. However, telehealth and teletherapy options became more widely adopted to address the disruption in services. Many therapists and healthcare providers began offering remote consultations and therapy sessions. The rapid acceptance of telehealth systems by the patient's caregivers/family was prompted by the rising anxiety levels in ASD patients and the possibility of contracting COVID-19, as these patients come under vulnerable categories. Additionally, the market expanded during COVID-19 due to the increased use of online sources to buy drugs for autism.

However, despite the growing demand for effective medications and clinical studies for autism, no medication has yet been able to completely alleviate any of the main symptoms of autism spectrum disease. despite numerous attempts, there hasn't been any concrete proof in the modern-day era of targeted treatments demonstrating any drug's efficacy for treating the condition's primary symptoms. The development of treatments is consequently made more difficult, which lowers the demand for therapies for people with autism spectrum disorders. Therefore, the absence of approved medications to treat patients may hinder the market's expansion.

Type Outlook

Based on type, the market is characterized into antipsychotic drugs, selective serotonin reuptake inhibitors, stimulants, sleep medications, and others. The stimulants segment garnered the highest revenue share in the market in 2022. The segment's expansion can be attributed to patients' increasing access to and availability of medications. The U.S. FDA has licensed several stimulants for use in the treatment of autistic people, including Dexedrine, Focalin, Vyvanse, Adderall, and Ritalin. When adequately supplied to patients, these medications reduce their symptoms by 80%. The high efficacy of the stimulants may, therefore, draw in new target customers and diversify the source of income.

Application Outlook

On the basis of application, the market is classified into autistic disorder, asperger syndrome, pervasive developmental disorder, and others. The asperger syndrome segment recorded a significant revenue share in the market in 2022. Individuals with Asperger's syndrome typically have difficulty with social interactions. They may struggle with understanding nonverbal cues such as facial expressions and body language, which can make it challenging to engage in typical social exchanges. A common trait among individuals with Asperger's syndrome is limited eye contact during conversations. They may not maintain specific levels of eye contact during social interactions. People with Asperger's may find it challenging to engage in pretend play or imagine scenarios that differ from their experiences.

Distribution Channel Outlook

By distribution channel, the market is divided into hospital pharmacy, retail pharmacy, and online pharmacy. The retail pharmacy segment witnessed the maximum revenue share in the market in 2022. Drugs like anticonvulsants, tricyclic antidepressants, stimulants, SSRIs, and anxiety meds are widely accessible at retail pharmacies. This widespread availability of different medications is responsible for the growth of the market segment. According to a June 2021 article, 30% to 50% of all ASD patients are thought to have taken at least one of the medications mentioned above. As a result, the segment growth is significantly driven by the rising ASD population.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment procured the highest revenue share in the market in 2022. The prevalence of ASD has increased in North America and globally. Increased awareness improved diagnostic criteria, and better access to healthcare services have contributed to higher diagnosis rates. As more individuals are diagnosed with ASD, the demand for treatment and support services has increased. In many parts of North America, there has been progress in securing insurance coverage for autism-related therapies and interventions. Laws and regulations mandating insurance coverage for ASD treatments have expanded access to care.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd., Bristol Myers Squibb Company, Merck & Co., Inc., Novartis AG, Eli Lilly And Company, Pfizer Inc., Johnson & Johnson, Otsuka Pharmaceutical Co., Ltd., Yamo Pharmaceuticals, and Curemark LLC

Scope of the Study

Market Segments covered in the Report:

By Type

• Stimulants
• Antipsychotic Drugs
• Selective Serotonin Reuptake Inhibitors
• Sleep Medications
• Others

By Application

• Autistic Disorder
• Asperger Syndrome
• Pervasive Developmental Disorder
• Others

By Distribution Channel

• Retail Pharmacy
• Hospital Pharmacy
• Online Pharmacy

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• F. Hoffmann-La Roche Ltd.
• Bristol Myers Squibb Company
• Merck & Co., Inc.
• Novartis AG
• Eli Lilly And Company
• Pfizer Inc.
• Johnson & Johnson
• Otsuka Pharmaceutical Co., Ltd.
• Yamo Pharmaceuticals
• Curemark LLC

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Autism Spectrum Disorder Treatment Market, by Type
  • 1.4.2 Global Autism Spectrum Disorder Treatment Market, by Application
  • 1.4.3 Global Autism Spectrum Disorder Treatment Market, by Distribution Channel
  • 1.4.4 Global Autism Spectrum Disorder Treatment Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market at a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints
• 3.3 Porter Five Forces Analysis

Chapter 4. Global Autism Spectrum Disorder Treatment Market, by Type

• 4.1 Global Stimulants Market, by Region
• 4.2 Global Antipsychotic Drugs Market, by Region
• 4.3 Global Selective Serotonin Reuptake Inhibitors Market, by Region
• 4.4 Global Sleep Medications Market, by Region
• 4.5 Global Others Market, by Region

Chapter 5. Global Autism Spectrum Disorder Treatment Market, by Application

• 5.1 Global Autistic Disorder Market, by Region
• 5.2 Global Asperger Syndrome Market, by Region
• 5.3 Global Pervasive Developmental Disorder Market, by Region
• 5.4 Global Others Market, by Region

Chapter 6. Global Autism Spectrum Disorder Treatment Market, by Distribution Channel

• 6.1 Global Retail Pharmacy Market, by Region
• 6.2 Global Hospital Pharmacy Market, by Region
• 6.3 Global Online Pharmacy Market, by Region

Chapter 7. Global Autism Spectrum Disorder Treatment Market, by Region

• 7.1 North America Autism Spectrum Disorder Treatment Market
  • 7.1.1 North America Autism Spectrum Disorder Treatment Market, by Type
    • 7.1.1.1 North America Stimulants Market, by Country
    • 7.1.1.2 North America Antipsychotic Drugs Market, by Country
    • 7.1.1.3 North America Selective Serotonin Reuptake Inhibitors Market, by Country
    • 7.1.1.4 North America Sleep Medications Market, by Country
    • 7.1.1.5 North America Others Market, by Country
  • 7.1.2 North America Autism Spectrum Disorder Treatment Market, by Application
    • 7.1.2.1 North America Autistic Disorder Market, by Country
    • 7.1.2.2 North America Asperger Syndrome Market, by Country
    • 7.1.2.3 North America Pervasive Developmental Disorder Market, by Country
    • 7.1.2.4 North America Others Market, by Country
  • 7.1.3 North America Autism Spectrum Disorder Treatment Market, by Distribution Channel
    • 7.1.3.1 North America Retail Pharmacy Market, by Country
    • 7.1.3.2 North America Hospital Pharmacy Market, by Country
    • 7.1.3.3 North America Online Pharmacy Market, by Country
  • 7.1.4 North America Autism Spectrum Disorder Treatment Market, by Country
    • 7.1.4.1 US Autism Spectrum Disorder Treatment Market
      • 7.1.4.1.1 US Autism Spectrum Disorder Treatment Market, by Type
      • 7.1.4.1.2 US Autism Spectrum Disorder Treatment Market, by Application
      • 7.1.4.1.3 US Autism Spectrum Disorder Treatment Market, by Distribution Channel
    • 7.1.4.2 Canada Autism Spectrum Disorder Treatment Market
      • 7.1.4.2.1 Canada Autism Spectrum Disorder Treatment Market, by Type
      • 7.1.4.2.2 Canada Autism Spectrum Disorder Treatment Market, by Application
      • 7.1.4.2.3 Canada Autism Spectrum Disorder Treatment Market, by Distribution Channel
    • 7.1.4.3 Mexico Autism Spectrum Disorder Treatment Market
      • 7.1.4.3.1 Mexico Autism Spectrum Disorder Treatment Market, by Type
      • 7.1.4.3.2 Mexico Autism Spectrum Disorder Treatment Market, by Application
      • 7.1.4.3.3 Mexico Autism Spectrum Disorder Treatment Market, by Distribution Channel
    • 7.1.4.4 Rest of North America Autism Spectrum Disorder Treatment Market
      • 7.1.4.4.1 Rest of North America Autism Spectrum Disorder Treatment Market, by Type
      • 7.1.4.4.2 Rest of North America Autism Spectrum Disorder Treatment Market, by Application
      • 7.1.4.4.3 Rest of North America Autism Spectrum Disorder Treatment Market, by Distribution Channel
• 7.2 Europe Autism Spectrum Disorder Treatment Market
  • 7.2.1 Europe Autism Spectrum Disorder Treatment Market, by Type
    • 7.2.1.1 Europe Stimulants Market, by Country
    • 7.2.1.2 Europe Antipsychotic Drugs Market, by Country
    • 7.2.1.3 Europe Selective Serotonin Reuptake Inhibitors Market, by Country
    • 7.2.1.4 Europe Sleep Medications Market, by Country
    • 7.2.1.5 Europe Others Market, by Country
  • 7.2.2 Europe Autism Spectrum Disorder Treatment Market, by Application
    • 7.2.2.1 Europe Autistic Disorder Market, by Country
    • 7.2.2.2 Europe Asperger Syndrome Market, by Country
    • 7.2.2.3 Europe Pervasive Developmental Disorder Market, by Country
    • 7.2.2.4 Europe Others Market, by Country
  • 7.2.3 Europe Autism Spectrum Disorder Treatment Market, by Distribution Channel
    • 7.2.3.1 Europe Retail Pharmacy Market, by Country
    • 7.2.3.2 Europe Hospital Pharmacy Market, by Country
    • 7.2.3.3 Europe Online Pharmacy Market, by Country
  • 7.2.4 Europe Autism Spectrum Disorder Treatment Market, by Country
    • 7.2.4.1 Germany Autism Spectrum Disorder Treatment Market
      • 7.2.4.1.1 Germany Autism Spectrum Disorder Treatment Market, by Type
      • 7.2.4.1.2 Germany Autism Spectrum Disorder Treatment Market, by Application
      • 7.2.4.1.3 Germany Autism Spectrum Disorder Treatment Market, by Distribution Channel
    • 7.2.4.2 UK Autism Spectrum Disorder Treatment Market
      • 7.2.4.2.1 UK Autism Spectrum Disorder Treatment Market, by Type
      • 7.2.4.2.2 UK Autism Spectrum Disorder Treatment Market, by Application
      • 7.2.4.2.3 UK Autism Spectrum Disorder Treatment Market, by Distribution Channel
    • 7.2.4.3 France Autism Spectrum Disorder Treatment Market
      • 7.2.4.3.1 France Autism Spectrum Disorder Treatment Market, by Type
      • 7.2.4.3.2 France Autism Spectrum Disorder Treatment Market, by Application
      • 7.2.4.3.3 France Autism Spectrum Disorder Treatment Market, by Distribution Channel
    • 7.2.4.4 Russia Autism Spectrum Disorder Treatment Market
      • 7.2.4.4.1 Russia Autism Spectrum Disorder Treatment Market, by Type
      • 7.2.4.4.2 Russia Autism Spectrum Disorder Treatment Market, by Application
      • 7.2.4.4.3 Russia Autism Spectrum Disorder Treatment Market, by Distribution Channel
    • 7.2.4.5 Spain Autism Spectrum Disorder Treatment Market
      • 7.2.4.5.1 Spain Autism Spectrum Disorder Treatment Market, by Type
      • 7.2.4.5.2 Spain Autism Spectrum Disorder Treatment Market, by Application
      • 7.2.4.5.3 Spain Autism Spectrum Disorder Treatment Market, by Distribution Channel
    • 7.2.4.6 Italy Autism Spectrum Disorder Treatment Market
      • 7.2.4.6.1 Italy Autism Spectrum Disorder Treatment Market, by Type
      • 7.2.4.6.2 Italy Autism Spectrum Disorder Treatment Market, by Application
      • 7.2.4.6.3 Italy Autism Spectrum Disorder Treatment Market, by Distribution Channel
    • 7.2.4.7 Rest of Europe Autism Spectrum Disorder Treatment Market
      • 7.2.4.7.1 Rest of Europe Autism Spectrum Disorder Treatment Market, by Type
      • 7.2.4.7.2 Rest of Europe Autism Spectrum Disorder Treatment Market, by Application
      • 7.2.4.7.3 Rest of Europe Autism Spectrum Disorder Treatment Market, by Distribution Channel
• 7.3 Asia Pacific Autism Spectrum Disorder Treatment Market
  • 7.3.1 Asia Pacific Autism Spectrum Disorder Treatment Market, by Type
    • 7.3.1.1 Asia Pacific Stimulants Market, by Country
    • 7.3.1.2 Asia Pacific Antipsychotic Drugs Market, by Country
    • 7.3.1.3 Asia Pacific Selective Serotonin Reuptake Inhibitors Market, by Country
    • 7.3.1.4 Asia Pacific Sleep Medications Market, by Country
    • 7.3.1.5 Asia Pacific Others Market, by Country
  • 7.3.2 Asia Pacific Autism Spectrum Disorder Treatment Market, by Application
    • 7.3.2.1 Asia Pacific Autistic Disorder Market, by Country
    • 7.3.2.2 Asia Pacific Asperger Syndrome Market, by Country
    • 7.3.2.3 Asia Pacific Pervasive Developmental Disorder Market, by Country
    • 7.3.2.4 Asia Pacific Others Market, by Country
  • 7.3.3 Asia Pacific Autism Spectrum Disorder Treatment Market, by Distribution Channel
    • 7.3.3.1 Asia Pacific Retail Pharmacy Market, by Country
    • 7.3.3.2 Asia Pacific Hospital Pharmacy Market, by Country
    • 7.3.3.3 Asia Pacific Online Pharmacy Market, by Country
  • 7.3.4 Asia Pacific Autism Spectrum Disorder Treatment Market, by Country
    • 7.3.4.1 China Autism Spectrum Disorder Treatment Market
      • 7.3.4.1.1 China Autism Spectrum Disorder Treatment Market, by Type
      • 7.3.4.1.2 China Autism Spectrum Disorder Treatment Market, by Application
      • 7.3.4.1.3 China Autism Spectrum Disorder Treatment Market, by Distribution Channel
    • 7.3.4.2 Japan Autism Spectrum Disorder Treatment Market
      • 7.3.4.2.1 Japan Autism Spectrum Disorder Treatment Market, by Type
      • 7.3.4.2.2 Japan Autism Spectrum Disorder Treatment Market, by Application
      • 7.3.4.2.3 Japan Autism Spectrum Disorder Treatment Market, by Distribution Channel
    • 7.3.4.3 India Autism Spectrum Disorder Treatment Market
      • 7.3.4.3.1 India Autism Spectrum Disorder Treatment Market, by Type
      • 7.3.4.3.2 India Autism Spectrum Disorder Treatment Market, by Application
      • 7.3.4.3.3 India Autism Spectrum Disorder Treatment Market, by Distribution Channel
    • 7.3.4.4 South Korea Autism Spectrum Disorder Treatment Market
      • 7.3.4.4.1 South Korea Autism Spectrum Disorder Treatment Market, by Type
      • 7.3.4.4.2 South Korea Autism Spectrum Disorder Treatment Market, by Application
      • 7.3.4.4.3 South Korea Autism Spectrum Disorder Treatment Market, by Distribution Channel
    • 7.3.4.5 Singapore Autism Spectrum Disorder Treatment Market
      • 7.3.4.5.1 Singapore Autism Spectrum Disorder Treatment Market, by Type
      • 7.3.4.5.2 Singapore Autism Spectrum Disorder Treatment Market, by Application
      • 7.3.4.5.3 Singapore Autism Spectrum Disorder Treatment Market, by Distribution Channel
    • 7.3.4.6 Malaysia Autism Spectrum Disorder Treatment Market
      • 7.3.4.6.1 Malaysia Autism Spectrum Disorder Treatment Market, by Type
      • 7.3.4.6.2 Malaysia Autism Spectrum Disorder Treatment Market, by Application
      • 7.3.4.6.3 Malaysia Autism Spectrum Disorder Treatment Market, by Distribution Channel
    • 7.3.4.7 Rest of Asia Pacific Autism Spectrum Disorder Treatment Market
      • 7.3.4.7.1 Rest of Asia Pacific Autism Spectrum Disorder Treatment Market, by Type
      • 7.3.4.7.2 Rest of Asia Pacific Autism Spectrum Disorder Treatment Market, by Application
      • 7.3.4.7.3 Rest of Asia Pacific Autism Spectrum Disorder Treatment Market, by Distribution Channel
• 7.4 LAMEA Autism Spectrum Disorder Treatment Market
  • 7.4.1 LAMEA Autism Spectrum Disorder Treatment Market, by Type
    • 7.4.1.1 LAMEA Stimulants Market, by Country
    • 7.4.1.2 LAMEA Antipsychotic Drugs Market, by Country
    • 7.4.1.3 LAMEA Selective Serotonin Reuptake Inhibitors Market, by Country
    • 7.4.1.4 LAMEA Sleep Medications Market, by Country
    • 7.4.1.5 LAMEA Others Market, by Country
  • 7.4.2 LAMEA Autism Spectrum Disorder Treatment Market, by Application
    • 7.4.2.1 LAMEA Autistic Disorder Market, by Country
    • 7.4.2.2 LAMEA Asperger Syndrome Market, by Country
    • 7.4.2.3 LAMEA Pervasive Developmental Disorder Market, by Country
    • 7.4.2.4 LAMEA Others Market, by Country
  • 7.4.3 LAMEA Autism Spectrum Disorder Treatment Market, by Distribution Channel
    • 7.4.3.1 LAMEA Retail Pharmacy Market, by Country
    • 7.4.3.2 LAMEA Hospital Pharmacy Market, by Country
    • 7.4.3.3 LAMEA Online Pharmacy Market, by Country
  • 7.4.4 LAMEA Autism Spectrum Disorder Treatment Market, by Country
    • 7.4.4.1 Brazil Autism Spectrum Disorder Treatment Market
      • 7.4.4.1.1 Brazil Autism Spectrum Disorder Treatment Market, by Type
      • 7.4.4.1.2 Brazil Autism Spectrum Disorder Treatment Market, by Application
      • 7.4.4.1.3 Brazil Autism Spectrum Disorder Treatment Market, by Distribution Channel
    • 7.4.4.2 Argentina Autism Spectrum Disorder Treatment Market
      • 7.4.4.2.1 Argentina Autism Spectrum Disorder Treatment Market, by Type
      • 7.4.4.2.2 Argentina Autism Spectrum Disorder Treatment Market, by Application
      • 7.4.4.2.3 Argentina Autism Spectrum Disorder Treatment Market, by Distribution Channel
    • 7.4.4.3 UAE Autism Spectrum Disorder Treatment Market
      • 7.4.4.3.1 UAE Autism Spectrum Disorder Treatment Market, by Type
      • 7.4.4.3.2 UAE Autism Spectrum Disorder Treatment Market, by Application
      • 7.4.4.3.3 UAE Autism Spectrum Disorder Treatment Market, by Distribution Channel
    • 7.4.4.4 Saudi Arabia Autism Spectrum Disorder Treatment Market
      • 7.4.4.4.1 Saudi Arabia Autism Spectrum Disorder Treatment Market, by Type
      • 7.4.4.4.2 Saudi Arabia Autism Spectrum Disorder Treatment Market, by Application
      • 7.4.4.4.3 Saudi Arabia Autism Spectrum Disorder Treatment Market, by Distribution Channel
    • 7.4.4.5 South Africa Autism Spectrum Disorder Treatment Market
      • 7.4.4.5.1 South Africa Autism Spectrum Disorder Treatment Market, by Type
      • 7.4.4.5.2 South Africa Autism Spectrum Disorder Treatment Market, by Application
      • 7.4.4.5.3 South Africa Autism Spectrum Disorder Treatment Market, by Distribution Channel
    • 7.4.4.6 Nigeria Autism Spectrum Disorder Treatment Market
      • 7.4.4.6.1 Nigeria Autism Spectrum Disorder Treatment Market, by Type
      • 7.4.4.6.2 Nigeria Autism Spectrum Disorder Treatment Market, by Application
      • 7.4.4.6.3 Nigeria Autism Spectrum Disorder Treatment Market, by Distribution Channel
    • 7.4.4.7 Rest of LAMEA Autism Spectrum Disorder Treatment Market
      • 7.4.4.7.1 Rest of LAMEA Autism Spectrum Disorder Treatment Market, by Type
      • 7.4.4.7.2 Rest of LAMEA Autism Spectrum Disorder Treatment Market, by Application
      • 7.4.4.7.3 Rest of LAMEA Autism Spectrum Disorder Treatment Market, by Distribution Channel

Chapter 8. Company Profiles

• 8.1 F. Hoffmann-La Roche Ltd.
  • 8.1.1 Company Overview
  • 8.1.2 Financial Analysis
  • 8.1.3 Segmental and Regional Analysis
  • 8.1.4 Research & Development Expense
  • 8.1.5 SWOT Analysis
• 8.2 Bristol Myers Squibb Company
  • 8.2.1 Company Overview
  • 8.2.2 Financial Analysis
  • 8.2.3 Regional Analysis
  • 8.2.4 Research & Development Expenses
  • 8.2.5 SWOT Analysis
• 8.3 Merck & Co., Inc.
  • 8.3.1 Company Overview
  • 8.3.2 Financial Analysis
  • 8.3.3 Segmental and Regional Analysis
  • 8.3.4 Research & Development Expenses
  • 8.3.5 SWOT Analysis
• 8.4 Novartis AG
  • 8.4.1 Company Overview
  • 8.4.2 Financial Analysis
  • 8.4.3 Segmental and Regional Analysis
  • 8.4.4 Research & Development Expense
  • 8.4.5 SWOT Analysis
• 8.5 Eli Lilly And Company
  • 8.5.1 Company Overview
  • 8.5.2 Financial Analysis
  • 8.5.3 Regional Analysis
  • 8.5.4 Research & Development Expenses
  • 8.5.5 SWOT Analysis
• 8.6 Pfizer, Inc.
  • 8.6.1 Company Overview
  • 8.6.2 Financial Analysis
  • 8.6.3 Regional & Segmental Analysis
  • 8.6.4 Research & Development Expense
  • 8.6.5 SWOT Analysis
• 8.7 Johnson & Johnson
  • 8.7.1 Company Overview
  • 8.7.2 Financial Analysis
  • 8.7.3 Segmental & Regional Analysis
  • 8.7.4 Research & Development Expenses
  • 8.7.5 SWOT Analysis
• 8.8 Otsuka Pharmaceutical Co., Ltd.
  • 8.8.1 Company Overview
  • 8.8.2 SWOT Analysis
• 8.9 Yamo Pharmaceuticals
  • 8.9.1 Company Overview
  • 8.9.2 SWOT Analysis
• 8.10. Curemark, LLC
  • 8.10.1 Company Overview
  • 8.10.2 SWOT Analysis

Chapter 9. Winning imperatives of Autism Spectrum Disorder Treatment Market